Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Sri Krishna Metcom IPO and Vanta Bioscience IPO.
Sri Krishna Metcom IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Vanta Bioscience IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Sri Krishna Metcom IPO | Vanta Bioscience IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Microsec Capital Ltd | Inventure Merchant Banker Services Pvt Ltd |
| Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | DRHP  |
|
| RHP | RHP |
|
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Sri Krishna Metcom IPO is up to ₹19.25 Cr whereas the issue size of the Vanta Bioscience IPO is up to ₹7.56 Cr. The final issue price of Sri Krishna Metcom IPO is ₹55.00 per share and of Vanta Bioscience IPO is ₹50.00 per share.
| Sri Krishna Metcom IPO | Vanta Bioscience IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹55.00 per share | ₹50.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 3000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 35,00,000 shares | 15,12,000 shares |
| Issue Size Total (Amount) | up to ₹19.25 Cr | up to ₹7.56 Cr |
Sri Krishna Metcom IPO opens on Sep 14, 2017, while Vanta Bioscience IPO opens on Sep 25, 2017. The closing date of Sri Krishna Metcom IPO and Vanta Bioscience IPO is Sep 18, 2017, and Sep 27, 2017, respectively.
| Sri Krishna Metcom IPO | Vanta Bioscience IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 14, 2017 | Sep 25, 2017 |
| Issue Close | Sep 18, 2017 | Sep 27, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Sri Krishna Metcom IPO P/E ratio is , as compared to Vanta Bioscience IPO P/E ratio of .
| Sri Krishna Metcom IPO | Vanta Bioscience IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Sri Krishna Metcom IPO retail investors (RII) are offered 17,50,000 shares while in Vanta Bioscience IPO retail investors are offered 17,50,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Sri Krishna Metcom IPO and in Vanta Bioscience IPO.
| Sri Krishna Metcom IPO | Vanta Bioscience IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 0 shares | |
| NII | 17,50,000 shares | |
| RII | 17,50,000 shares | |
| Employee | ||
| Others | ||
| Total | 35,00,000 shares |
Sri Krishna Metcom IPO subscribed in total, whereas Vanta Bioscience IPO subscribed .
| Sri Krishna Metcom IPO | Vanta Bioscience IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
